Drug Schedules, Laws, and Regulations around the world are implemented, enforced, and put in place for a variety of reasons. Drug schedules are enforced in the united states by the Drug Enforcement Administration (DEA) and a list is maintained which is broadly accepted by many governments and scientific communities to put parameters are acceptable medical use and abuse or dependency potential of a given drug.
The abuse rate is the largest determining factor for which schedule a given drug is placed within and the schedule has corresponding penalties under the law as well as sentencing guidelines for the judicial system.
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
| class_name | category_name | drug_name |
| Schedule I | Opiates. | Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide) |
| Schedule I | Opiates. | Acetylmethadol |
| Schedule I | Opiates. | Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) |
| Schedule I | Opiates. | Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; also known as acryloylfentanyl) |
| Schedule I | Opiates. | AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) |
| Schedule I | Opiates. | Allylprodine |
| Schedule I | Opiates. | Alphacetylmethadol (except levo-alphacetylmethadol also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM) |
| Schedule I | Opiates. | Alphameprodine |
| Schedule I | Opiates. | Alphamethadol |
| Schedule I | Opiates. | alpha-Methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine) |
| Schedule I | Opiates. | alpha-Methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) |
| Schedule I | Opiates. | Benzethidine |
| Schedule I | Opiates. | Betacetylmethadol |
| Schedule I | Opiates. | beta-Hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide) |
| Schedule I | Opiates. | beta-Hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide) |
| Schedule I | Opiates. | beta-Hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide) |
| Schedule I | Opiates. | Betameprodine |
| Schedule I | Opiates. | Betamethadol |
| Schedule I | Opiates. | beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also known as β-methyl fentanyl) |
| Schedule I | Opiates. | beta’-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as β’-phenyl fentanyl; 3-phenylpropanoyl fentanyl) |
| Schedule I | Opiates. | Betaprodine |
| Schedule I | Opiates. | Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide) |
| Schedule I | Opiates. | Clonitazene |
| Schedule I | Opiates. | Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) |
| Schedule I | Opiates. | Cyclopentyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide) |
| Schedule I | Opiates. | Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide) |
| Schedule I | Opiates. | Dextromoramide |
| Schedule I | Opiates. | Diampromide |
| Schedule I | Opiates. | Diethylthiambutene |
| Schedule I | Opiates. | Difenoxin |
| Schedule I | Opiates. | Dimenoxadol |
| Schedule I | Opiates. | Dimepheptanol |
| Schedule I | Opiates. | Dimethylthiambutene |
| Schedule I | Opiates. | Dioxaphetyl butyrate |
| Schedule I | Opiates. | Dipipanone |
| Schedule I | Opiates. | Ethylmethylthiambutene |
| Schedule I | Opiates. | Etonitazene |
| Schedule I | Opiates. | Etoxeridine |
| Schedule I | Opiates. | Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate) |
| Schedule I | Opiates. | 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide; also known as para-fluoroisobutyryl fentanyl) |
| Schedule I | Opiates. | 2′-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2′-fluoro 2-fluorofentanyl) |
| Schedule I | Opiates. | Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) |
| Schedule I | Opiates. | Furethidine |
| Schedule I | Opiates. | Hydroxypethidine |
| Schedule I | Opiates. | Isobutyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide) |
| Schedule I | Opiates. | Ketobemidone |
| Schedule I | Opiates. | Levomoramide |
| Schedule I | Opiates. | Levophenacylmorphan |
| Schedule I | Opiates. | Methoxyacetyl fentanyl (2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) |
| Schedule I | Opiates. | 4′-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) |
| Schedule I | Opiates. | 3-Methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide) |
| Schedule I | Opiates. | 3-Methylthiofentanyl (N-[3-methyl-1-(2-thienylethyl)-4-piperidinyl]-N-phenylpropanamide) |
| Schedule I | Opiates. | Morpheridine |
| Schedule I | Opiates. | MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) |
| Schedule I | Opiates. | MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) |
| Schedule I | Opiates. | Noracymethadol |
| Schedule I | Opiates. | Norlevorphanol |
| Schedule I | Opiates. | Normethadone |
| Schedule I | Opiates. | Norpipanone |
| Schedule I | Opiates. | Ocfentanil (N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide) |
| Schedule I | Opiates. | ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide) |
| Schedule I | Opiates. | ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl) |
| Schedule I | Opiates. | ortho-Fluorofentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide); also known as 2-fluorofentanyl) |
| Schedule I | Opiates. | ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) |
| Schedule I | Opiates. | ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl) |
| Schedule I | Opiates. | ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl methoxyacetyl fentanyl) |
| Schedule I | Opiates. | para-Chloroisobutyryl fentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) |
| Schedule I | Opiates. | para-Fluorobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) |
| Schedule I | Opiates. | para-Fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide) |
| Schedule I | Opiates. | para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) |
| Schedule I | Opiates. | para-Methoxybutyryl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) |
| Schedule I | Opiates. | para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl) |
| Schedule I | Opiates. | PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine) |
| Schedule I | Opiates. | Phenadoxone |
| Schedule I | Opiates. | Phenampromide |
| Schedule I | Opiates. | Phenomorphan |
| Schedule I | Opiates. | Phenoperidine |
| Schedule I | Opiates. | Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl) |
| Schedule I | Opiates. | Piritramide |
| Schedule I | Opiates. | Proheptazine |
| Schedule I | Opiates. | Properidine |
| Schedule I | Opiates. | Propiram |
| Schedule I | Opiates. | Racemoramide |
| Schedule I | Opiates. | Tetrahydrofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide) |
| Schedule I | Opiates. | Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide) |
| Schedule I | Opiates. | Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranylfentanyl; thiophene fentanyl) |
| Schedule I | Opiates. | Tilidine |
| Schedule I | Opiates. | Trimeperidine |
| Schedule I | Opiates. | U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) |
| Schedule I | Opiates. | Valeryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide) |
| Schedule I | Opium derivatives. | Acetorphine |
| Schedule I | Opium derivatives. | Acetyldihydrocodeine |
| Schedule I | Opium derivatives. | Benzylmorphine |
| Schedule I | Opium derivatives. | Codeine methylbromide |
| Schedule I | Opium derivatives. | Codeine-N-Oxide |
| Schedule I | Opium derivatives. | Cyprenorphine |
| Schedule I | Opium derivatives. | Desomorphine |
| Schedule I | Opium derivatives. | Dihydromorphine |
| Schedule I | Opium derivatives. | Drotebanol |
| Schedule I | Opium derivatives. | Etorphine (except hydrochloride salt) |
| Schedule I | Opium derivatives. | Heroin |
| Schedule I | Opium derivatives. | Hydromorphinol |
| Schedule I | Opium derivatives. | Methyldesorphine |
| Schedule I | Opium derivatives. | Methyldihydromorphine |
| Schedule I | Opium derivatives. | Morphine methylbromide |
| Schedule I | Opium derivatives. | Morphine methylsulfonate |
| Schedule I | Opium derivatives. | Morphine-N-Oxide |
| Schedule I | Opium derivatives. | Myrophine |
| Schedule I | Opium derivatives. | Nicocodeine |
| Schedule I | Opium derivatives. | Nicomorphine |
| Schedule I | Opium derivatives. | Normorphine |
| Schedule I | Opium derivatives. | Pholcodine |
| Schedule I | Opium derivatives. | Thebacon |
| Schedule I | Hallucinogenic substances. | Alpha-ethyltryptamine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: etryptamine; Monase; α-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; α-ET; and AET. |
| Schedule I | Hallucinogenic substances. | 4-bromo-2,5-dimethoxy-amphetamine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: 4-bromo-2,5-dimethoxy-α-methylphenethylamine; 4-bromo-2,5-DMA |
| Schedule I | Hallucinogenic substances. | 4-Bromo-2,5-dimethoxyphenethylamine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus. |
| Schedule I | Hallucinogenic substances. | 2,5-dimethoxyamphetamine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: 2,5-dimethoxy-α-methylphenethylamine; 2,5-DMA |
| Schedule I | Hallucinogenic substances. | 2,5-dimethoxy-4-ethylamphet-amine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: DOET |
| Schedule I | Hallucinogenic substances. | 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7) |
| Schedule I | Hallucinogenic substances. | 4-methoxyamphetamine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: 4-methoxy-α-methylphenethylamine; paramethoxyamphetamine, PMA |
| Schedule I | Hallucinogenic substances. | 5-methoxy-3,4-methylenedioxy-amphetamine |
| Schedule I | Hallucinogenic substances. | 4-methyl-2,5-dimethoxy-amphetamine |
| Schedule I | Hallucinogenic substances. | Some trade and other names: 4-methyl-2,5-dimethoxy-α-methylphenethylamine; “DOM”; and “STP” |
| Schedule I | Hallucinogenic substances. | 3,4-methylenedioxy amphetamine |
| Schedule I | Hallucinogenic substances. | 3,4-methylenedioxymethamphetamine (MDMA) |
| Schedule I | Hallucinogenic substances. | 3,4-methylenedioxy-N-ethylamphetamine (also known as N-ethyl-alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA |
| Schedule I | Hallucinogenic substances. | N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA |
| Schedule I | Hallucinogenic substances. | 3,4,5-trimethoxy amphetamine |
| Schedule I | Hallucinogenic substances. | 5-methoxy-N,N-dimethyltryptamine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: 5-methoxy-3-[2-(dimethylamino)ethyl]indole; 5-MeO-DMT |
| Schedule I | Hallucinogenic substances. | Alpha-methyltryptamine (other name: AMT) |
| Schedule I | Hallucinogenic substances. | Bufotenine |
| Schedule I | Hallucinogenic substances. | Some trade and other names: 3-(β-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N, N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine |
| Schedule I | Hallucinogenic substances. | Diethyltryptamine |
| Schedule I | Hallucinogenic substances. | Some trade and other names: N,N-Diethyltryptamine; DET |
| Schedule I | Hallucinogenic substances. | Dimethyltryptamine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: DMT |
| Schedule I | Hallucinogenic substances. | 5-methoxy-N,N-diisopropyltryptamine (other name: 5-MeO-DIPT) |
| Schedule I | Hallucinogenic substances. | Ibogaine |
| Schedule I | Hallucinogenic substances. | Some trade and other names: 7-Ethyl-6,6β,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1′, 2′:1,2] azepino [5,4-b] indole; Tabernanthe iboga |
| Schedule I | Hallucinogenic substances. | Lysergic acid diethylamide |
| Schedule I | Hallucinogenic substances. | Marihuana |
| Schedule I | Hallucinogenic substances. | Mescaline |
| Schedule I | Hallucinogenic substances. | Parahexyl—Some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl |
| Schedule I | Hallucinogenic substances. | Peyote |
| Schedule I | Hallucinogenic substances. | Meaning all parts of the plant presently classified botanically as Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from any part of such plant, and every compound, manufacture, salts, derivative, mixture, or preparation of such plant, its seeds or extracts |
| Schedule I | Hallucinogenic substances. | (Interprets 21 USC 812(c), Schedule I(12)) |
| Schedule I | Hallucinogenic substances. | N-ethyl-3-piperidyl benzilate |
| Schedule I | Hallucinogenic substances. | N-methyl-3-piperidyl benzilate |
| Schedule I | Hallucinogenic substances. | Psilocybin |
| Schedule I | Hallucinogenic substances. | Psilocyn |
| Schedule I | Hallucinogenic substances. | Tetrahydrocannabinols |
| Schedule I | Hallucinogenic substances. | Meaning tetrahydrocannabinols, except as in paragraph (d)(31)of this section, naturally contained in a plant of the genus Cannabis (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis plant, or in the resinous extractives of such plant, and/or synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to those substances contained in the plant, such as the following: |
| Schedule I | Hallucinogenic substances. | 1 cis or trans tetrahydrocannabinol, and their optical isomers |
| Schedule I | Hallucinogenic substances. | 6 cis or trans tetrahydrocannabinol, and their optical isomers |
| Schedule I | Hallucinogenic substances. | 3, 4 cis or trans tetrahydrocannabinol, and its optical isomers |
| Schedule I | Hallucinogenic substances. | (Since nomenclature of these substances is not internationally standardized, compounds of these structures, regardless of numerical designation of atomic positions covered.) |
| Schedule I | Hallucinogenic substances. | Tetrahydrocannabinols does not include any material, compound, mixture, or preparation that falls within the definition of hemp set forth in 7 U.S.C. 1639o. |
| Schedule I | Hallucinogenic substances. | Ethylamine analog of phencyclidine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine, N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE |
| Schedule I | Hallucinogenic substances. | Pyrrolidine analog of phencyclidine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP |
| Schedule I | Hallucinogenic substances. | Thiophene analog of phencyclidine |
| Schedule I | Hallucinogenic substances. | Some trade or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP |
| Schedule I | Hallucinogenic substances. | 1-[1-(2-thienyl)cyclohexyl]pyrrolidine |
| Schedule I | Hallucinogenic substances. | Some other names: TCPy |
| Schedule I | Hallucinogenic substances. | 4-methylmethcathinone (Mephedrone) |
| Schedule I | Hallucinogenic substances. | 3,4-methylenedioxypyrovalerone (MDPV) |
| Schedule I | Hallucinogenic substances. | 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E) |
| Schedule I | Hallucinogenic substances. | 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D) |
| Schedule I | Hallucinogenic substances. | 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C) |
| Schedule I | Hallucinogenic substances. | 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I) |
| Schedule I | Hallucinogenic substances. | 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2) |
| Schedule I | Hallucinogenic substances. | 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-4) |
| Schedule I | Hallucinogenic substances. | 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H) |
| Schedule I | Hallucinogenic substances. | 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N) |
| Schedule I | Hallucinogenic substances. | 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P) |
| Schedule I | Hallucinogenic substances. | 3,4-Methylenedioxy-N-methylcathinone (Methylone) |
| Schedule I | Hallucinogenic substances. | (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone (UR-144) |
| Schedule I | Hallucinogenic substances. | [1-(5-fluoro-pentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (5-fluoro-UR-144, XLR11) |
| Schedule I | Hallucinogenic substances. | N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA, AKB48) |
| Schedule I | Hallucinogenic substances. | quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate (PB-22; QUPIC) |
| Schedule I | Hallucinogenic substances. | quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (5-fluoro-PB-22; 5F-PB-22) |
| Schedule I | Hallucinogenic substances. | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) |
| Schedule I | Hallucinogenic substances. | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (ADB-PINACA) |
| Schedule I | Hallucinogenic substances. | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe, 2C-I-NBOMe) |
| Schedule I | Hallucinogenic substances. | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe, 2C-C-NBOMe) |
| Schedule I | Hallucinogenic substances. | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe, 2C-B-NBOMe) |
| Schedule I | Hallucinogenic substances. | Marihuana Extract |
| Schedule I | Hallucinogenic substances. | Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, containing greater than 0.3% delta-9-tetrahydrocannabinol on a dry weight basis, other than the separated resin (whether crude or purified) obtained from the plant. |
| Schedule I | Hallucinogenic substances. | 4-methyl-N-ethylcathinone (4-MEC) |
| Schedule I | Hallucinogenic substances. | 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) |
| Schedule I | Hallucinogenic substances. | alpha-pyrrolidinopentiophenone (α-PVP) |
| Schedule I | Hallucinogenic substances. | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone, bk-MBDB) |
| Schedule I | Hallucinogenic substances. | 2-(methylamino)-1-phenylpentan-1-one (pentedrone) |
| Schedule I | Hallucinogenic substances. | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1- one (pentylone, bk-MBDP) |
| Schedule I | Hallucinogenic substances. | 4-fluoro-N-methylcathinone (4-FMC; flephedrone) |
| Schedule I | Hallucinogenic substances. | 3-fluoro-N-methylcathinone (3-FMC) |
| Schedule I | Hallucinogenic substances. | 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone) |
| Schedule I | Hallucinogenic substances. | alpha-pyrrolidinobutiophenone (α-PBP) |
| Schedule I | Hallucinogenic substances. | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA) |
| Schedule I | Hallucinogenic substances. | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) |
| Schedule I | Hallucinogenic substances. | [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone (THJ-2201) |
| Schedule I | Hallucinogenic substances. | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide, its optical, positional, and geometric isomers, salts and salts of isomers (Other names: MAB-CHMINACA; ADB-CHMINACA) |
| Schedule I | Hallucinogenic substances. | methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: 5F–ADB; 5F–MDMB–PINACA) |
| Schedule I | Hallucinogenic substances. | methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate (Other names: 5F–AMB) |
| Schedule I | Hallucinogenic substances. | N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other names: 5F–APINACA, 5F–AKB48) |
| Schedule I | Hallucinogenic substances. | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (Other names: ADB–FUBINACA) |
| Schedule I | Hallucinogenic substances. | methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB–CHMICA, MMB–CHMINACA) |
| Schedule I | Hallucinogenic substances. | methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (Other names: MDMB–FUBINACA) |
| Schedule I | Hallucinogenic substances. | methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate, (FUB-AMB, MMB-FUBINACA, AMB-FUBINACA) |
| Schedule I | Hallucinogenic substances. | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one (ethylone) |
| Schedule I | Hallucinogenic substances. | Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate (Other names: NM2201; CBL2201) |
| Schedule I | Hallucinogenic substances. | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (Other name: 5F-AB-PINACA) |
| Schedule I | Hallucinogenic substances. | 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (Other names: 4-CN-CUMYL-BUTINACA; 4-cyanoCUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78) |
| Schedule I | Hallucinogenic substances. | methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (Other names: MMB-CHMICA; AMB-CHMICA) |
| Schedule I | Hallucinogenic substances. | 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide (Other name: 5F-CUMYL-P7AICA) |
| Schedule I | Hallucinogenic substances. | N-ethylpentylone (Other names: ephylone, 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one) |
| Schedule I | Hallucinogenic substances. | methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (4F–MDMB–BINACA, 4F–MDMB–BUTINACA) |
| Schedule I | Hallucinogenic substances. | 1-(4-methoxyphenyl)-N-methylpropan-2-amine (other names: para-methoxymethamphetamine, PMMA) |
| Schedule I | Depressants. | gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate) |
| Schedule I | Depressants. | Mecloqualone |
| Schedule I | Depressants. | Methaqualone |
| Schedule I | Stimulants. | Aminorex (Some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or 4,5-dihydro-5-phenly-2-oxazolamine) |
| Schedule I | Stimulants. | N-Benzylpiperazine (some other names: BZP, 1-benzylpiperazine) |
| Schedule I | Stimulants. | Cathinone |
| Schedule I | Stimulants. | Some trade or other names: 2-amino-1-phenyl-1-propanone, alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone |
| Schedule I | Stimulants. | 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) |
| Schedule I | Stimulants. | Fenethylline |
| Schedule I | Stimulants. | Methcathinone (Some other names: 2-(methylamino)-propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one; alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone;N-methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers |
| Schedule I | Stimulants. | (±)cis-4-methylaminorex ((±)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) |
| Schedule I | Stimulants. | N-ethylamphetamine |
| Schedule I | Stimulants. | N,N-dimethylamphetamine (also known as N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine) |
| Schedule I | Cannabimimetic agents. | 5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (CP-47,497) |
| Schedule I | Cannabimimetic agents. | 5-(1,1-dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (cannabicyclohexanol or CP-47,497 C8-homolog) |
| Schedule I | Cannabimimetic agents. | 1-pentyl-3-(1-naphthoyl)indole (JWH-018 and AM678) |
| Schedule I | Cannabimimetic agents. | 1-butyl-3-(1-naphthoyl)indole (JWH-073) |
| Schedule I | Cannabimimetic agents. | 1-hexyl-3-(1-naphthoyl)indole (JWH-019) |
| Schedule I | Cannabimimetic agents. | 1-[2-(4-morpholinyl)ethyl]-3-(1-naphthoyl)indole (JWH- 200) |
| Schedule I | Cannabimimetic agents. | 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250) |
| Schedule I | Cannabimimetic agents. | 1-pentyl-3-[1-(4-methoxynaphthoyl)]indole (JWH-081) |
| Schedule I | Cannabimimetic agents. | 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122) |
| Schedule I | Cannabimimetic agents. | 1-pentyl-3-(4-chloro-1-naphthoyl)indole (JWH-398) |
| Schedule I | Cannabimimetic agents. | 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM2201) |
| Schedule I | Cannabimimetic agents. | 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole (AM694) |
| Schedule I | Cannabimimetic agents. | 1-pentyl-3-[(4-methoxy)-benzoyl]indole (SR-19 and RCS-4) |
| Schedule I | Cannabimimetic agents. | 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole 7008 (SR-18 and RCS-8) |
| Schedule I | Cannabimimetic agents. | 1-pentyl-3-(2-chlorophenylacetyl)indole (JWH-203) |
| Schedule I | Temporary listing of substances subject to emergency scheduling. | (1)-[Reserved] |
| Schedule I | Temporary listing of substances subject to emergency scheduling. | Fentanyl-related substances, their isomers, esters, ethers, salts and salts of isomers, esters and ethers |
Schedule II drugs, substances, or chemicals are defined as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. These drugs are also considered dangerous. Some examples of Schedule II drugs are: combination products with less than 15 milligrams of hydrocodone per dosage unit (Vicodin), cocaine, methamphetamine, methadone, hydromorphone (Dilaudid), meperidine (Demerol), oxycodone (OxyContin), fentanyl, Dexedrine, Adderall, and Ritalin.
| class_name | category_name | drug_name |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Codeine |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Dihydroetorphine |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Ethylmorphine |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Etorphine hydrochloride |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Granulated opium |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Hydrocodone |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Hydromorphone |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Metopon |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Morphine |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Noroxymorphone |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Opium extracts |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Opium fluid |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Oripavine |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Oxycodone |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Oxymorphone |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Powdered opium |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Raw opium |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Thebaine |
| Schedule II | Substances, vegetable origin or chemical synthesis. | Tincture of opium |
| Schedule II | Opiates. | Alfentanil |
| Schedule II | Opiates. | Alphaprodine |
| Schedule II | Opiates. | Anileridine |
| Schedule II | Opiates. | Bezitramide |
| Schedule II | Opiates. | Bulk dextropropoxyphene (non-dosage forms) |
| Schedule II | Opiates. | Carfentanil |
| Schedule II | Opiates. | Dihydrocodeine |
| Schedule II | Opiates. | Diphenoxylate |
| Schedule II | Opiates. | Fentanyl |
| Schedule II | Opiates. | Isomethadone |
| Schedule II | Opiates. | Levo-alphacetylmethadol [Some other names: levo-alpha-acetylmethadol, levomethadyl acetate, LAAM] |
| Schedule II | Opiates. | Levomethorphan |
| Schedule II | Opiates. | Levorphanol |
| Schedule II | Opiates. | Metazocine |
| Schedule II | Opiates. | Methadone |
| Schedule II | Opiates. | Methadone-Intermediate, 4-cyano-2-dimethylamino-4,4-diphenyl butane |
| Schedule II | Opiates. | Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid |
| Schedule II | Opiates. | Oliceridine (N-[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine) |
| Schedule II | Opiates. | Pethidine (meperidine) |
| Schedule II | Opiates. | Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine |
| Schedule II | Opiates. | Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate |
| Schedule II | Opiates. | Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid |
| Schedule II | Opiates. | Phenazocine |
| Schedule II | Opiates. | Piminodine |
| Schedule II | Opiates. | Racemethorphan |
| Schedule II | Opiates. | Racemorphan |
| Schedule II | Opiates. | Remifentanil |
| Schedule II | Opiates. | Sufentanil |
| Schedule II | Opiates. | Tapentadol |
| Schedule II | Opiates. | Thiafentanil |
| Schedule II | Stimulants. | Amphetamine, its salts, optical isomers, and salts of its optical isomers |
| Schedule II | Stimulants. | Methamphetamine, its salts, isomers, and salts of its isomers |
| Schedule II | Stimulants. | Phenmetrazine and its salts |
| Schedule II | Stimulants. | Methylphenidate |
| Schedule II | Stimulants. | Lisdexamfetamine, its salts, isomers, and salts of its isomers |
| Schedule II | Depressants. | Amobarbital |
| Schedule II | Depressants. | Glutethimide |
| Schedule II | Depressants. | Pentobarbital |
| Schedule II | Depressants. | Phencyclidine |
| Schedule II | Depressants. | Secobarbital |
| Schedule II | Hallucinogenic substances. | Nabilone |
| Schedule II | Hallucinogenic substances. | [Another name for nabilone: (+/-)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6, 6-dimethyl-9H-dibenzo[b,d]pyran-9-one] |
| Schedule II | Hallucinogenic substances. | Dronabinol [(-)-delta-9-trans tetrahydrocannabinol] in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration |
| Schedule II | Immediate precursors. | Phenylacetone |
| Schedule II | Immediate precursors. | Some trade or other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone; |
Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone
| class_name | category_name | drug_name |
| Schedule III | Stimulants. | Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under §1308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances |
| Schedule III | Stimulants. | Benzphetamine |
| Schedule III | Stimulants. | Chlorphentermine |
| Schedule III | Stimulants. | Clortermine |
| Schedule III | Stimulants. | Phendimetrazine |
| Schedule III | Depressants. | Any compound, mixture or preparation containing: |
| Schedule III | Depressants. | Amobarbital |
| Schedule III | Depressants. | Secobarbital |
| Schedule III | Depressants. | Pentobarbital |
| Schedule III | Depressants. | or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule. |
| Schedule III | Depressants. | Any suppository dosage form containing: |
| Schedule III | Depressants. | Amobarbital |
| Schedule III | Depressants. | Secobarbital |
| Schedule III | Depressants. | Pentobarbital |
| Schedule III | Depressants. | or any salt of any of these drugs and approved by the Food and Drug Administration for marketing only as a suppository. |
| Schedule III | Depressants. | Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof |
| Schedule III | Depressants. | Chlorhexadol |
| Schedule III | Depressants. | Embutramide |
| Schedule III | Depressants. | Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act |
| Schedule III | Depressants. | Ketamine, its salts, isomers, and salts of isomers |
| Schedule III | Depressants. | [Some other names for ketamine: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone] |
| Schedule III | Depressants. | Lysergic acid |
| Schedule III | Depressants. | Lysergic acid amide |
| Schedule III | Depressants. | Methyprylon |
| Schedule III | Depressants. | Perampanel, and its salts, isomers, and salts of isomers |
| Schedule III | Depressants. | Sulfondiethylmethane |
| Schedule III | Depressants. | Sulfonethylmethane |
| Schedule III | Depressants. | Sulfonmethane |
| Schedule III | Depressants. | Tiletamine and zolazepam or any salt thereof |
| Schedule III | Depressants. | Some trade or other names for a tiletamine-zolazepam combination product: Telazol |
| Schedule III | Depressants. | Some trade or other names for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone |
| Schedule III | Depressants. | Some trade or other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one, flupyrazapon |
| Schedule III | Anabolic Steroids. | Anabolic steroids (see §1300.01 of this chapter) |
| Schedule III | Anabolic Steroids. | [Reserved] |
| Schedule III | Hallucinogenic substances. | Dronabinol in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product |
| Schedule III | Hallucinogenic substances. | [Some other names for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol] or (-)-delta-9-(trans)-tetrahydrocannabinol] |
| Schedule III | Hallucinogenic substances. | [Reserved] |
Schedule IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol
| class_name | category_name | drug_name |
| Schedule IV | Narcotic drugs. | Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit |
| Schedule IV | Narcotic drugs. | Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane) |
| Schedule IV | Narcotic drugs. | 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) |
| Schedule IV | Depressants. | Alfaxalone |
| Schedule IV | Depressants. | Alprazolam |
| Schedule IV | Depressants. | Barbital |
| Schedule IV | Depressants. | Brexanolone |
| Schedule IV | Depressants. | Bromazepam |
| Schedule IV | Depressants. | Camazepam |
| Schedule IV | Depressants. | Carisoprodol |
| Schedule IV | Depressants. | Chloral betaine |
| Schedule IV | Depressants. | Chloral hydrate |
| Schedule IV | Depressants. | Chlordiazepoxide |
| Schedule IV | Depressants. | Clobazam |
| Schedule IV | Depressants. | Clonazepam |
| Schedule IV | Depressants. | Clorazepate |
| Schedule IV | Depressants. | Clotiazepam |
| Schedule IV | Depressants. | Cloxazolam |
| Schedule IV | Depressants. | Delorazepam |
| Schedule IV | Depressants. | Diazepam |
| Schedule IV | Depressants. | Dichloraphenazone |
| Schedule IV | Depressants. | Estazolam |
| Schedule IV | Depressants. | Ethchlorvynol |
| Schedule IV | Depressants. | Ethinamate |
| Schedule IV | Depressants. | Ethyl loflazepate |
| Schedule IV | Depressants. | Fludiazepam |
| Schedule IV | Depressants. | Flunitrazepam |
| Schedule IV | Depressants. | Flurazepam |
| Schedule IV | Depressants. | Fospropofol |
| Schedule IV | Depressants. | Halazepam |
| Schedule IV | Depressants. | Haloxazolam |
| Schedule IV | Depressants. | Ketazolam |
| Schedule IV | Depressants. | Lemborexant |
| Schedule IV | Depressants. | Loprazolam |
| Schedule IV | Depressants. | Lorazepam |
| Schedule IV | Depressants. | Lormetazepam |
| Schedule IV | Depressants. | Mebutamate |
| Schedule IV | Depressants. | Medazepam |
| Schedule IV | Depressants. | Meprobamate |
| Schedule IV | Depressants. | Methohexital |
| Schedule IV | Depressants. | Methylphenobarbital (mephobarbital) |
| Schedule IV | Depressants. | Midazolam |
| Schedule IV | Depressants. | Nimetazepam |
| Schedule IV | Depressants. | Nitrazepam |
| Schedule IV | Depressants. | Nordiazepam |
| Schedule IV | Depressants. | Oxazepam |
| Schedule IV | Depressants. | Oxazolam |
| Schedule IV | Depressants. | Paraldehyde |
| Schedule IV | Depressants. | Petrichloral |
| Schedule IV | Depressants. | Phenobarbital |
| Schedule IV | Depressants. | Pinazepam |
| Schedule IV | Depressants. | Prazepam |
| Schedule IV | Depressants. | Quazepam |
| Schedule IV | Depressants. | Remimazolam |
| Schedule IV | Depressants. | Suvorexant |
| Schedule IV | Depressants. | Temazepam |
| Schedule IV | Depressants. | Tetrazepam |
| Schedule IV | Depressants. | Triazolam |
| Schedule IV | Depressants. | Zaleplon |
| Schedule IV | Depressants. | Zolpidem |
| Schedule IV | Depressants. | Zopiclone |
| Schedule IV | Fenfluramine. | Fenfluramine |
| Schedule IV | Lorcaserin. | Lorcaserin |
| Schedule IV | Stimulants. | Cathine ((+)-norpseudoephedrine) |
| Schedule IV | Stimulants. | Diethylpropion |
| Schedule IV | Stimulants. | Fencamfamin |
| Schedule IV | Stimulants. | Fenproporex |
| Schedule IV | Stimulants. | Mazindol |
| Schedule IV | Stimulants. | Mefenorex |
| Schedule IV | Stimulants. | Modafinil |
| Schedule IV | Stimulants. | Pemoline (including organometallic complexes and chelates thereof) |
| Schedule IV | Stimulants. | Phentermine |
| Schedule IV | Stimulants. | Pipradrol |
| Schedule IV | Stimulants. | Serdexmethylphenidate |
| Schedule IV | Stimulants. | Sibutramine |
| Schedule IV | Stimulants. | Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)) |
| Schedule IV | Stimulants. | SPA ((-)-1-dimethylamino-1,2-diphenylethane) |
| Schedule IV | Other substances. | Pentazocine |
| Schedule IV | Other substances. | Butorphanol (including its optical isomers) |
| Schedule IV | Other substances. | Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers |
Schedule V drugs, substances, or chemicals are defined as drugs with lower potential for abuse than Schedule IV and consist of preparations containing limited quantities of certain narcotics. Schedule V drugs are generally used for antidiarrheal, antitussive, and analgesic purposes.
Some examples of Schedule V drugs are cough preparations with less than 200 milligrams of codeine or per 100 milliliters (Robitussin AC), Lomotil, Motofen, Lyrica, and Parepectolin. They may be abused in extremely large quantities but in general, they are not as easy to abuse as the other drug schedules.
Drug schedules protect society by making sure that the distribution of certain drugs is thoroughly watched and penalties for selling drugs with a lower schedule have harsher consequences so that drug dealers are deterred from selling them on the street. Not all countries have the same penalties as the United States for associated drugs.
In the past 100 years, laws and regulations for drug use have evolved greatly and some countries even make drugs legal so the united states have been placed on the schedule I drug list. Some countries also ban alcohol completely while the united states make it legal and on to anyone 18 and older.
While alcohol was prohibited in the 1930s, that’s no longer the case. In fact, even the drinking age has risen from 18 to 21. Drug schedules, laws, and regulations seem to be an ever-evolving system to help maintain the safety and well-being of the public so that commonly abused drugs are harder to obtain.
A consolidation of drug schedule chart that has the main categories of substances in each drug schedule can be found here.
In conclusion, drug schedules serve as a crucial regulatory framework for categorizing controlled substances based on their medical use, the potential for abuse, and dependence potential. By having a clear classification system, governments, and regulatory agencies can better monitor and control the production, distribution, and prescription of these substances, ultimately ensuring public safety and health.
It is important to note that drug schedules may differ between countries, reflecting variations in legal systems and societal attitudes toward certain substances. As our understanding of these substances evolves and new substances emerge, drug schedules must be periodically reviewed and updated to maintain their relevance and effectiveness.
While drug scheduling systems help protect public health, they can also create barriers to accessing medications for legitimate medical purposes, particularly when a drug is deemed to have a high potential for abuse. Therefore, striking a balance between ensuring public safety and providing access to medications for patients in need remains an ongoing challenge.
Finally, it is essential for individuals to understand the drug scheduling system in their country or region, as it may have implications for the accessibility and legality of certain medications or substances. This knowledge will enable them to make informed decisions about their use and advocate for policy changes as needed.
Get confidential help 24/7. Call now for:
Related Articles
Get Help Now
DEA. 10 July, 2018. Drug Scheduling. Retrieved from https://www.dea.gov/drug-information/drug-scheduling on 20 December, 2022
Dews, P. B., & DeWeese, J. (1977). Schedules of Reinforcement. Handbook of Psychopharmacology, 107–150.
Drug directory: Browse medications by letter – goodrx. (2022). Retrieved December 21, 2022, from https://www.goodrx.com/drugs
Nutt, D., King, L. & Nichols, D. Effects of Schedule I drug laws on neuroscience research and treatment innovation. Nat Rev Neurosci 14, 577–585 (2013).
Martin-Latry, K., Cazaux, J., Lafitte, M., & Couffinhal, T. (2014). Negative impact of physician prescribed drug dosing schedule requirements on patient adherence to cardiovascular drugs. Pharmacoepidemiology and Drug Safety, 23(10), 1088–1092.
Medical Advice Disclaimer
Magnified Health Systems aims to improve the quality of life for people struggling with substance use or mental health disorder with fact-based content about the nature of behavioral health conditions, treatment options and their related outcomes. We publish material that is researched, cited, edited and reviewed by licensed medical professionals. The information we provide is not intended to be a substitute for professional medical advice, diagnosis or treatment. It should not be used in place of the advice of your physician or other qualified healthcare providers.
Dr. Bickley graduated from U.C. Irvine with honors: Phi Beta Kappa, Golden Key International Honor Society, Cum Laude. He has been featured on national radio and print media. He is also a frequent lecturer at National Conferences. He holds an A.S. degree in Drug & Alcohol Studies, and two B.A. degrees in Criminology & Psychology, and masters and doctoral degree in Clinical Psychology. He is a licensed California Drug & Alcohol Counselor Level II, a licensed Clinical Supervisor and is certified in treating Eating Disorders.
Call Us Now, Our Admissions Team Is Standing By And Available 24/7.
Head Office Location:
1530 N Federal Hwy Lake Worth, FL 33460
Contact & Feedback:
We are here for you.
We are here for you, Call us and get started!
